Bristol-Myers (BMY) Extends Tender Offer for Medarex (MEDX) to August 26
More News related to BMY
- Notable 52-Week High's and Low's: BMY, JCG, PBR, SLW, GOOG, INCY, NTAP, QADI, GOLD, BONT Higher; SPWRB Low
- Asterand Announces Extension of Agreement with Bristol-Myers Squibb
- U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
- Barclays Maintains an 'Overweight' on Bristol-Myers (BMY); Raises PT
- Trading Overview for Poniard Pharmaceuticals Inc. Issued by Beacon Equity
More News related to MEDX
- Bristol-Myers Squibb (BMY) Completes Acquisition of Medarex
- Bristol-Myers Squibb (BMY) Completes Tender Offer for Medarex (MEDX)
- Notable Mergers and Acquisitions of the Day 8/21: MNOV/AVGN, BMY/MEDX, ORCL/JAVA
- Bristol-Myers (BMY) Extends Tender Offer for Medarex (MEDX) to August 26
- Medarex (MEDX) Reports Solid Q2 Results
Bristol-Myers Squibb Company (NYSE: BMY) announced today that it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Puma Acquisition Corporation, to purchase all outstanding shares of common stock of Medarex (NASDAQ: MEDX) until 12:00 midnight (New York City time) on August 26, 2009, unless further extended.
The tender offer that was originally scheduled to expire at 12:00 midnight (New York City time) on August 24, 2009 was extended, with the consent of Medarex, in connection with the parties reaching an agreement in principle to settle the legal proceedings pending in connection with the tender offer. All other terms and conditions of the tender offer remain unchanged.
Related Categories
Corporate NewsMergers and Acquisitions
Stocks Mentioned
-0.27
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
